BACKGROUND:Bisphosphonate can irritate the gastrointestinal mucosa and increase the risk of esophageal or gastric cancer. The relatively high prevalence of upper gastrointestinal cancers and the widespread use of bisphosphonate in Korea call for further investigation. We conducted a case-control study to evaluate the risk of esophageal or gastric cancer after exposure to oral bisphosphonates in Korean patients with osteoporosis. METHODS:We used the National Health Insurance Service-National Sample Cohort database of Korea from 2002 to 2013. Among osteoporotic patients (>40 years), cases were defined as incident diagnosis of esophageal or gastric cancer between 2006 and 2013. For each case, four controls were matched for age, sex, and income...
BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Al...
Bisphosphonates represent a unique class of drugs that effectively treat and prevent a variety of bo...
<p>Association between oral bisphosphonate exposure and esophageal or gastric cancer according to CD...
[[abstract]]BACKGROUND: Esophageal cancer has been associated with oral bisphosphonate use, but curr...
Background: Esophageal cancer has been associated with oral bisphosphonate use, but current data are...
BACKGROUND: Concerns have been raised as to the safety of bisphosphonates; in particular a possible ...
<div><h3>Background</h3><p>Concerns have been raised as to the safety of bisphosphonates; in particu...
Objective: To examine the hypothesis that risk of oesophageal, but not of gastric or colorectal, can...
Objective: To examine the hypothesis that risk of oesophageal, but not of gastric or colorectal, can...
BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Alt...
Introduction: Bisphosphonates are becominga common treatment for osteoporosis particularly afterdisc...
Background: Data on the effect of oral bisphosphonates (BPs) on risk of upper gastrointestinal compl...
Background: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Alt...
Background: Data on the effect of oral bisphosphonates (BPs) on risk of upper gastrointestinal compl...
Background: Bisphosphonates are the most commonly prescribed osteoporosis drugs but long-term effect...
BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Al...
Bisphosphonates represent a unique class of drugs that effectively treat and prevent a variety of bo...
<p>Association between oral bisphosphonate exposure and esophageal or gastric cancer according to CD...
[[abstract]]BACKGROUND: Esophageal cancer has been associated with oral bisphosphonate use, but curr...
Background: Esophageal cancer has been associated with oral bisphosphonate use, but current data are...
BACKGROUND: Concerns have been raised as to the safety of bisphosphonates; in particular a possible ...
<div><h3>Background</h3><p>Concerns have been raised as to the safety of bisphosphonates; in particu...
Objective: To examine the hypothesis that risk of oesophageal, but not of gastric or colorectal, can...
Objective: To examine the hypothesis that risk of oesophageal, but not of gastric or colorectal, can...
BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Alt...
Introduction: Bisphosphonates are becominga common treatment for osteoporosis particularly afterdisc...
Background: Data on the effect of oral bisphosphonates (BPs) on risk of upper gastrointestinal compl...
Background: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Alt...
Background: Data on the effect of oral bisphosphonates (BPs) on risk of upper gastrointestinal compl...
Background: Bisphosphonates are the most commonly prescribed osteoporosis drugs but long-term effect...
BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Al...
Bisphosphonates represent a unique class of drugs that effectively treat and prevent a variety of bo...
<p>Association between oral bisphosphonate exposure and esophageal or gastric cancer according to CD...